Wexford Capital LP Immucell Corp Transaction History
Wexford Capital LP
- $569 Million
- Q4 2024
Shares
3 transactions
Others Institutions Holding ICCC
# of Institutions
27Shares Held
1.21MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA226KShares$1.13 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny137KShares$687,6840.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$662,6450.0% of portfolio
-
Dauntless Investment Group, LLC Commerce Township, MI131KShares$658,5980.71% of portfolio
-
Bleichroeder LP New York, NY102KShares$510,0010.16% of portfolio
About IMMUCELL CORP
- Ticker ICCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,746,860
- Market Cap $38.9M
- Description
- ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...